Ngā hua rapu - Daniella Magen

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial mā Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, Hadas Shasha-Lavsky, David J. Sas, Mini Michael, Anne-Laure S, Julien Hogan, Richard Willey, John M. Gansner, Daniella Magen

Connect to this object online.